Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Here is the latest financial fact sheet of Aventis Pharma. For more details, see the Aventis Pharma quarterly results and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.7 |
No. of shares | m | 23.03 |
% ch week | % | -5.2 |
% ch 1-mth | % | -0.2 |
% ch 12-mth | % | 26.8 |
52 week H/L | Rs | 6,840.1/4,705.6 |
No. of Mths Year Ending |
12 Dec-13 |
12 Dec-14 |
12 Dec-15 |
12 Dec-16 |
12 Dec-17 |
5-Yr Chart Click to enlarge
|
---|
SANOFI INDIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,862 | 3,800 | 4,521 | 4,560 | 4,945 | |
Low | Rs | 2,450 | 2,500 | 3,445 | 4,400 | 3,901 | |
Sales per share (Unadj.) | Rs | 785.4 | 858.7 | 952.3 | 1,028.5 | 1,081.8 | |
Earnings per share (Unadj.) | Rs | 115.1 | 114.5 | 139.6 | 132.1 | 141.6 | |
Diluted earnings per share | Rs | 115.1 | 114.5 | 139.6 | 132.1 | 141.6 | |
Cash flow per share (Unadj.) | Rs | 155.2 | 156.4 | 188.7 | 183.7 | 185.9 | |
Dividends per share (Unadj.) | Rs | 45.00 | 45.00 | 65.00 | 68.00 | 33.00 | |
Adj. dividends per share | Rs | 45.00 | 45.00 | 65.00 | 68.00 | 33.00 | |
Dividend yield (eoy) | % | 1.7 | 1.4 | 1.6 | 1.5 | 0.7 | |
Book value per share (Unadj.) | Rs | 584.8 | 645.2 | 706.5 | 753.6 | 868.8 | |
Adj. book value per share | Rs | 584.8 | 645.2 | 706.5 | 753.6 | 868.8 | |
Shares outstanding (eoy) | m | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 3.4 | 3.7 | 4.2 | 4.4 | 4.1 | |
Avg P/E ratio | x | 23.1 | 27.5 | 28.5 | 33.9 | 31.2 | |
P/CF ratio (eoy) | x | 17.1 | 20.1 | 21.1 | 24.4 | 23.8 | |
Price / Book Value ratio | x | 4.5 | 4.9 | 5.6 | 5.9 | 5.1 | |
Dividend payout | % | 39.1 | 39.3 | 46.6 | 51.5 | 23.3 | |
Avg Mkt Cap | Rs m | 61,168 | 72,545 | 91,724 | 103,174 | 101,862 | |
No. of employees | `000 | 3.3 | 3.4 | 3.7 | 3.6 | 3.2 | |
Total wages/salary | Rs m | 2,421 | 2,882 | 3,333 | 3,553 | 3,685 | |
Avg. sales/employee | Rs Th | 5,496.4 | 5,735.2 | 5,987.0 | 6,537.7 | 7,691.9 | |
Avg. wages/employee | Rs Th | 735.7 | 836.0 | 909.9 | 980.7 | 1,137.7 | |
Avg. net profit/employee | Rs Th | 805.8 | 764.5 | 877.7 | 839.6 | 1,006.5 |
SANOFI INDIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 18,089 | 19,775 | 21,930 | 23,686 | 24,914 | |
Other income | Rs m | 579 | 643 | 514 | 664 | 807 | |
Total revenues | Rs m | 18,667 | 20,418 | 22,444 | 24,350 | 25,721 | |
Gross profit | Rs m | 3,979 | 3,389 | 4,591 | 5,351 | 5,372 | |
Depreciation | Rs m | 923 | 966 | 1,130 | 1,188 | 1,022 | |
Interest | Rs m | 4 | 5 | 4 | 23 | 11 | |
Profit before tax | Rs m | 3,631 | 3,061 | 3,970 | 4,804 | 5,146 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 254 | 666 | 839 | 0 | 0 | |
Tax | Rs m | 1,233 | 1,090 | 1,594 | 1,762 | 1,886 | |
Profit after tax | Rs m | 2,652 | 2,636 | 3,215 | 3,042 | 3,260 | |
Gross profit margin | % | 22.0 | 17.1 | 20.9 | 22.6 | 21.6 | |
Effective tax rate | % | 34.0 | 35.6 | 40.1 | 36.7 | 36.6 | |
Net profit margin | % | 14.7 | 13.3 | 14.7 | 12.8 | 13.1 |
SANOFI INDIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 9,471 | 12,628 | 12,437 | 15,753 | 14,432 | |
Current liabilities | Rs m | 4,689 | 6,558 | 4,945 | 5,021 | 6,010 | |
Net working cap to sales | % | 26.4 | 30.7 | 34.2 | 45.3 | 33.8 | |
Current ratio | x | 2.0 | 1.9 | 2.5 | 3.1 | 2.4 | |
Inventory Days | Days | 69 | 88 | 80 | 76 | 61 | |
Debtors Days | Days | 24 | 21 | 24 | 22 | 28 | |
Net fixed assets | Rs m | 8,348 | 8,582 | 8,771 | 8,098 | 7,991 | |
Share capital | Rs m | 230 | 230 | 230 | 230 | 230 | |
"Free" reserves | Rs m | 13,099 | 14,559 | 16,004 | 17,088 | 19,778 | |
Net worth | Rs m | 13,467 | 14,858 | 16,272 | 17,356 | 20,008 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 18,783 | 22,276 | 24,114 | 25,412 | 27,770 | |
Interest coverage | x | 865.5 | 638.6 | 993.5 | 209.9 | 468.8 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | |
Return on assets | % | 14.1 | 11.9 | 13.3 | 12.1 | 11.8 | |
Return on equity | % | 19.7 | 17.7 | 19.8 | 17.5 | 16.3 | |
Return on capital | % | 28.9 | 25.1 | 29.6 | 27.8 | 25.8 | |
Exports to sales | % | 23.0 | 24.2 | 24.2 | 24.5 | 0 | |
Imports to sales | % | 30.2 | 36.9 | 26.1 | 28.0 | 0 | |
Exports (fob) | Rs m | 4,152 | 4,788 | 5,312 | 5,801 | 0 | |
Imports (cif) | Rs m | 5,455 | 7,298 | 5,720 | 6,627 | 0 | |
Fx inflow | Rs m | 4,865 | 5,495 | 6,680 | 7,145 | 6,306 | |
Fx outflow | Rs m | 6,094 | 8,045 | 6,587 | 6,846 | 5,257 | |
Net fx | Rs m | -1,229 | -2,550 | 93 | 299 | 1,049 |
SANOFI INDIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,726 | 2,650 | 2,132 | 3,221 | 4,351 | |
From Investments | Rs m | -3,354 | 613 | 359 | -1,550 | -787 | |
From Financial Activity | Rs m | -1,050 | -1,217 | -1,470 | -1,802 | -1,884 | |
Net Cashflow | Rs m | -1,678 | 2,046 | 1,021 | -131 | 1,680 |
Share Holding
|
Company Information
|
CHM: Vijay Mallya | COMP SEC: K. Subramani | YEAR OF INC: 1956 | BSE CODE: 500674 | FV (Rs): 10 | DIV YIELD (%): 0.5 |
More Pharmaceuticals Company Fact Sheets: TORRENT PHARMA SHASUN PHARMA J.B.CHEMICALS WOCKHARDT LTD. PIRAMAL ENTERPRISES
Compare SANOFI INDIA With: TORRENT PHARMA SHASUN PHARMA J.B.CHEMICALS WOCKHARDT LTD. PIRAMAL ENTERPRISES
Compare SANOFI INDIA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
| |
The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.
For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
Should you subscribe to the IPO of Shalby Ltd?
Here's what you can expect from The 5 Minute Wrapup in the coming months and years.
More Views on NewsTanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.
Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...
A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.
The real estate sector is ready to make a comeback. This is the stock to consider buying.
While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.
More
| |